Swarup Mehta, PharmD, MBA, AAHIVE
Swarup Mehta was born and raised in Naperville, Illinios. He earned his PharmD and MBA at Drake University in Des Moines, Iowa in 2002. After graduation, Swarup worked for Walgreens Pharmacy in many Chicagoland locations. He is currently the Clinic Pharmacy Manager for Walgreens at Northstar Medical in Chicago. There, he specializes and counsels on HIV, hepatitis, and oncology. He is also an immunizer and offers a variety of vaccinations at his clinic. He has served on the TPAN board for three years and is the co-chair of the fundraising committee. Swarup received the 2009 Outstanding Health Care Advocate of the Year award from the AIDS Legal Council of Chicago. Working at the clinic pharmacies for Walgreens has given him the ability to build relationships with his patients and make their lives easier. He is doing what he loves.
Calvin “Cal” J. Cohen, MD, MS
Dr. Cal Cohen is research director of Harvard Vanguard Medical Associates and Community Research Initiative of New England in Boston, Massachusetts. He is also a clinical instructor at Harvard Medical School. In addition, he works as an HIV clinical management consultant and internist at
Harvard Pilgrim Health Care.
Dr. Cohen was co-chair of the Scientific Advisory Committee of amfAR community-based clinical trials network, and served as co-principal investigator of the
Harvard/BCH AIDS Clinical Trials Unit, AIDS Clinical Trials Group. He holds appointments at Brigham and Women’s Hospital and Beth Israel Hospital, both
in Boston.
In addition to caring for HIV-positive patients and directing clinical research at a large HIV community-based research site, Dr. Cohen is actively involved in evaluating new antiretroviral therapies, the durability and longevity of the benefits from such therapies, and issues regarding compliance and adherence.
Jeff Taylor
Jeff is a 25-year survivor of AIDS and cancer, and has been active in HIV research advocacy since enrolling in the AIDS Clinical Trials Group’s (ACTG) AZT trials in the late 80s. He served for five years on the ACTG’s Community Constituency Group (now CSS), where he was the community liaison to the Complications Research Agenda Committee (now OpMan), and was on the ACTG’s original metabolics focus group formed to study emerging lipodystrophy. Currently, he continues to serve on the University of California, San Diego Antiviral Research Center’s Community Advisory Board, and on the NCI’s AIDS Malignancy Consortium as a community representative. He is a vice-chair of the AIDS Treatment Activists Coalition’s Drug Development Committee, which meets regularly with pharmaceutical companies and the FDA on HIV drug development issues. Jeff resides in Palm Springs, where he produces a monthly treatment education series for area HIV patients and providers.
